Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,049,887 | 833,986 | 984,648 | 672,617 | 1,017,386 |
| Marketable Securities | 1,179,195 | 1,058,477 | 960,723 | 1,015,200 | 971,764 |
| Receivables | 239,044 | 219,919 | 181,621 | 203,074 | 196,133 |
| Inventories | 91,354 | 75,567 | 79,647 | 52,688 | 34,061 |
| TOTAL | $2,617,359 | $2,254,003 | $2,273,948 | $2,007,803 | $2,272,875 |
| Non-Current Assets | |||||
| PPE Net | 51,487 | 52,739 | 55,371 | 56,970 | 57,189 |
| Intangibles | 485,267 | 463,025 | 471,094 | 478,807 | 226,147 |
| Other Non-Current Assets | 96,364 | 99,337 | 98,354 | 100,120 | 77,944 |
| TOTAL | $633,118 | $615,101 | $624,819 | $635,897 | $361,280 |
| Total Assets | $3,250,477 | $2,869,104 | $2,898,767 | $2,643,700 | $2,634,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 369,666 | 591,978 | 569,631 | 546,927 | 262,021 |
| Accounts payable and accrued liabilities | 382,245 | 313,050 | 381,272 | 303,141 | 338,945 |
| TOTAL | $771,068 | $923,604 | $968,427 | $866,245 | $627,809 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,542,738 | 2,022,189 | 2,025,366 | 1,821,313 | 2,119,998 |
| Deferred Revenues | 1,192 | 498 | 2,040 | 1,691 | 9,760 |
| Other Non-Current Liabilities | 102,034 | 103,776 | 107,287 | 98,067 | 79,061 |
| TOTAL | $2,644,772 | $2,125,965 | $2,135,653 | $1,933,213 | $2,212,892 |
| Total Liabilities | $3,415,840 | $3,049,569 | $3,104,080 | $2,799,458 | $2,840,701 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,461 | 82,949 | 82,775 | 80,288 | 79,438 |
| Common Shares | 82 | 81 | 80 | 79 | 78 |
| Retained earnings | -2,883,542 | -2,967,038 | -2,964,229 | -2,829,264 | -2,845,160 |
| Other shareholders' equity | 6,017 | 8,466 | 10,501 | 5,930 | 7,356 |
| TOTAL | $-165,363 | $-180,465 | $-205,313 | $-155,758 | $-206,546 |
| Total Liabilities And Equity | $3,250,477 | $2,869,104 | $2,898,767 | $2,643,700 | $2,634,155 |